AlpInvest Partners B.V. Quant / Systematic

CIK: 0001512910 · Show all filings

Period: Q2 2014 (← Previous) (Next →)

Filing Date: Aug 14, 2014

Total Value ($000): $28,078 (100.0% shares, 0.0% debt)

Holdings (19)

Nuance Communications Inc 27.2%
Value ($000) $7,641 Shares 407,100 Est. Cost $19.52 Unrealized
LPLA LPL Finl Hldgs Inc 14.2%
Value ($000) $3,979 Shares 80,004 Est. Cost $36.43 Unrealized +33.1%
Ophthotech Corp 12.4%
Value ($000) $3,471 Shares 82,046 Est. Cost $42.31 Unrealized
Twitter Inc 6.7%
Value ($000) $1,888 Shares 46,071 Est. Cost $40.98 Unrealized
Barracuda Networks Inc 5.4%
Value ($000) $1,505 Shares 48,508 Est. Cost $31.03 Unrealized
Nimble Storage Inc 5.3%
Value ($000) $1,489 Shares 48,469 Est. Cost $30.72 Unrealized
AGIO Agios Pharmaceuticals Inc 4.7%
Value ($000) $1,327 Shares 28,956 Est. Cost $40.76 Unrealized 0.0%
Kythera Biopharmaceuticals I 4.5%
Value ($000) $1,277 Shares 33,271 Est. Cost $39.31 Unrealized
NOW ServiceNow Inc 4.2%
Value ($000) $1,191 Shares 19,230 Est. Cost $8.30 Unrealized +28.7%
Zeltiq Aesthetics Inc 2.7%
Value ($000) $760 Shares 50,011 Est. Cost $19.62 Unrealized
PCRX Pacira Pharmaceuticals Inc 2.6%
Value ($000) $735 Shares 7,996 Est. Cost $22.30 Unrealized +241.4%
GMED Globus Med Inc 2.5%
Value ($000) $714 Shares 29,861 Est. Cost $17.31 Unrealized +39.4%
BCC Boise Cascade Co Del 2.4%
Value ($000) $681 Shares 23,769 Est. Cost $19.87 Unrealized -9.8%
VIPS Vipshop Hldgs Ltd 1.8%
Value ($000) $511 Shares 2,722 Est. Cost $70.24 Unrealized
Relypsa Inc 0.9%
Value ($000) $255 Shares 10,495 Est. Cost $24.30 Unrealized
ChannelAdvisor Corp 0.9%
Value ($000) $251 Shares 9,504 Est. Cost $37.77 Unrealized
Hyperion Therapeutics Inc 0.7%
Value ($000) $207 Shares 7,920 Est. Cost $26.14 Unrealized
Groupon Inc 0.5%
Value ($000) $132 Shares 20,000 Est. Cost $4.86 Unrealized
YuMe Inc 0.2%
Value ($000) $64 Shares 10,922 Est. Cost $5.86 Unrealized